Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...

Wearables have become catalysts for a proactive approach to healthcare, predicting what is about to happen based on current ...

The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Artificial intelligence (AI) is transforming dietary management for diabetes and obesity, offering personalized nutrition plans, real-time glucose mon.

US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...

Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!